Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid

Authors

Anna Pankakoski (ORCID: https://orcid.org/0000-0001-7182-5892)
Jaana Panelius (ORCID: https://orcid.org/0000-0001-5733-2848)
Laura Huilaja (ORCID: https://orcid.org/0000-0002-7597-4323)
Outi Varpuluoma (ORCID: https://orcid.org/0000-0001-5831-2611)
Kaisa Tasanen (ORCID: https://orcid.org/0000-0001-8056-5949)
Jari Jokelainen (ORCID: https://orcid.org/0000-0003-4629-0560)
Päivi Leisti (ORCID: https://orcid.org/0000-0001-5655-8079)

Institutions

University of Helsinki (FI)
Oulu University Hospital (FI)
Helsinki University Hospital (FI)
University of Oulu (FI)

Publication Details

Journal: Acta Dermato Venereologica
Published: 2024-09-04
DOI: https://doi.org/10.2340/actadv.v104.40645
Primary Topic: Autoimmune Bullous Skin Diseases
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Amgen
Bristol-Myers Squibb
Eli Lilly and Company
Sanofi
Finska Läkaresällskapet
Suomen Ihotautilääkäriyhdistys
Oulun Yliopisto
Sigrid Juséliuksen Säätiö
Tutkijakoulu, Oulun Yliopiston
LEO Pharma
Sanofi Genzyme
UCB Pharma
Cilag

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid

Anna Pankakoski, Jaana Panelius, Laura Huilaja, Outi Varpuluoma et al.

Sep 4, 2024

5 links

Acta Dermato Venereologica

Autoimmune Bullous Skin Diseases

article

Type 2 Diabetes and its Treatment with Linagliptin are both Associated with Elevated Mortality in Bullous Pemphigoid

Anna Pankakoski, Jaana Panelius, Laura Huilaja, Outi Varpuluoma, Kaisa Tasanen, Jari Jokelainen, Päivi Leisti

September 4, 2024article en

Abstract

No abstract available for this paper.

Acta Dermato VenereologicaVol. 104

University of Helsinki (FI), Oulu University Hospital (FI), Helsinki University Hospital (FI), University of Oulu (FI)

Amgen, Bristol-Myers Squibb, Eli Lilly and Company, Sanofi, Finska Läkaresällskapet, Suomen Ihotautilääkäriyhdistys, Oulun Yliopisto, Sigrid Juséliuksen Säätiö, Tutkijakoulu, Oulun Yliopiston, LEO Pharma, Sanofi Genzyme, UCB Pharma, Cilag

Good health and well-being

Openalex Percentile: Top 76%

Autoimmune Bullous Skin Diseases

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.